Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combinatory Analysis of Cell-free and Circulating Tumor Cell DNAs Provides More Variants for Cancer Treatment.

Anticancer research - 1 Dec 2019

Lee Sun-Young, Chae Dong-Kyu, An Jahyun, Yoo Seokchan, Jung Sungmok, Chae Chang Hoon, Bhak Jong, Kim Byung Chul, Cho Dong-Hyu

Abstract excerpt

BACKGROUND/AIM: Non-invasive biomarker detection using DNA from cell-free circulating DNA (cfDNA) and circulating tumor cells (ctcDNA) are emerging as they can be used for early diagnosis, prognosis and therapeutic target selection for cancer. However, cfDNA and ctcDNA from the same patient have not yet been compared extensively on how different the genetic characteristics of the two are in terms of the overlap...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell-Free Nucleic Acids

Share to Cell Line, Tumor

Share to Circulating Tumor DNA

Share to DNA, Neoplasm

Share to Genital Neoplasms, Female

Share to High-Throughput Nucleotide Sequencing

Source

Identifiers

PMID: 31810925
DOI: 10.21873/anticanres.13875

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combinatory Analysis of Cell-free and Circulating Tumor Cell DNAs Provides More Variants for Cancer Treatment.PMID 31810925Read ↗

Strategies for improving detection of circulating tumor DNA using next generation sequencing.Semantic proximity Read ↗

Bioinformatics Analysis for Cell-Free Tumor DNA Sequencing Data.Semantic proximity Read ↗

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast CancerSemantic proximity Read ↗

NGS-Based Tumor-Informed Analysis of Circulating Tumor DNA.Semantic proximity Read ↗

Bioinformatics Analysis for Circulating Cell-Free DNA in CancerSemantic proximity Read ↗

Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.Semantic proximity Read ↗

Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer PatientsSemantic proximity Read ↗

Identifying the Common Cell-Free DNA Biomarkers across Seven Major Cancer TypesSemantic proximity Read ↗

Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patientsSemantic proximity Read ↗

Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?Semantic proximity Read ↗

Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sampleSemantic proximity Read ↗

Cancer-like fragmentomic characteristics of somatic variants in cell-free DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.